Clinical trial
Hyzaar Asia HEAALTH (0954A-950)
NCT00354991 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00354991 |
|---|---|
| Title | Hyzaar Asia HEAALTH (0954A-950) |
| Official title | An Open Label Study to Assess the Efficacy of Losartan/HCTZ Combination Therapy in Patients With Essential Hypertension Who Were Inadequately Controlled on Current Antihypertensive Monotherapy |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | losartan potassium (+) hydrochlorothiazide |
| Enrollment | 437 |
| Start date | Jun 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Jul 20, 2006 |
| Last update posted | May 9, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: